Literature DB >> 3956052

Comparison of four beta-blockers as assessed by 24-hour ECG recording.

B Escoubet, J F Leclercq, P Maison-Blanche, J M Poirier, B Gourmel, B Delhotal-Landes, P Coumel.   

Abstract

beta-Blockers are used as if they were equivalent. With ECG recordings in 42 patients we investigated the effect on sinus heart rate of four beta-blockers given at three successive daily doses. Heart rate was dose-dependently decreased by all drugs except acebutolol, the effect of which decreased at a higher dosage. The maximal effects of metoprolol, nadolol, and propranolol were similar but the drugs differed in potency (dosage producing 50% of maximal effect, calculated from the dose-effect relationships; nadolol, 0.3 mg/day; metoprolol, 120 mg/day; propranolol, 47 mg/day). Similar relationships were found with drug plasma concentrations (concentration producing 50% of maximal effect: nadolol, 3.5 ng/ml; metoprolol, 21 ng/ml; propranolol, 36 ng/ml) and with supine or upright heart rates and blood pressures. However, the drugs were not equivalent: In addition to its greater potency, nadolol differed from propranolol and metoprolol in the slope of its dose-response curve. We conclude that beta-blockers can be compared by ECG recordings and that nadolol is different from the other beta-blockers without intrinsic sympathomimetic activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3956052     DOI: 10.1038/clpt.1986.55

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  2 in total

1.  TIP39 modulates effects of novelty-induced arousal on memory.

Authors:  L Coutellier; A Logemann; J Kuo; M Rusnak; T B Usdin
Journal:  Genes Brain Behav       Date:  2010-09-29       Impact factor: 3.449

2.  Bidirectional Modulation of Alcohol-Associated Memory Reconsolidation through Manipulation of Adrenergic Signaling.

Authors:  Moritz J W Schramm; Barry J Everitt; Amy L Milton
Journal:  Neuropsychopharmacology       Date:  2015-08-17       Impact factor: 7.853

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.